Omics Approaches in Pancreatic Adenocarcinoma

Pancreatic ductal adenocarcinoma, which represents 80% of pancreatic cancers, is mainly diagnosed when treatment with curative intent is not possible. Consequently, the overall five-year survival rate is extremely dismal—around 5% to 7%. In addition, pancreatic cancer is expected to become the secon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: González-Borja, Iranzu, Viúdez, Antonio, Goñi, Saioa, Santamaria, Enrique, Carrasco-García, Estefania, Pérez-Sanz, Jairo, Hernández-García, Irene, Sala-Elarre, Pablo, Arrazubi, Virginia, Oyaga-Iriarte, Esther, Zárate, Ruth, Arévalo, Sara, Sayar, Onintza, Vera, Ruth, Fernández-Irigoyen, Joaquin
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721316/
https://ncbi.nlm.nih.gov/pubmed/31349663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11081052
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados